Living With HS: Tameka Carter’s Journey to Diagnosis and Treatment
Release Date: 01/02/2026
AI, HER2-Low, and the Future of Precision Oncology
MD Newsline
In this episode of MD Newsline, Dr Frederick Howard, breast oncologist at the University of Chicago and leader of a research group focused on AI-driven biomarker development, explores the rapidly evolving role of artificial intelligence in breast cancer care. Dr. Howard provides a comprehensive overview of how AI is being integrated into oncology—from radiographic imaging and digital pathology to clinical decision support and language models. He discusses both the promise and the practical challenges of deploying AI tools in real-world workflows, including validation standards, regulatory...
info_outline
Late-Stage Breast Cancer Diagnosis Among Black Women in the Mid-South
MD Newsline
In this episode of MD Newsline, Dr. Janeane N. Anderson, Assistant Professor at the University of Tennessee Health Science Center and breast cancer researcher, shares insights from the ACCESS Study—an innovative qualitative research initiative focused on understanding why Black women in the Mid-South region are disproportionately diagnosed with advanced-stage breast cancer. Dr. Anderson discusses structural barriers, community-based recruitment strategies, and the importance of centering lived experiences in oncology research. She also highlights the critical need for equitable research...
info_outline
Understanding Cancer Disparities, Mistrust, and Access to Care
MD Newsline
In this episode of MD Newsline, Dr. Jordonna Brown, a medical oncologist at Kings County Hospital in New York City, shares her frontline experience caring for patients in a safety-net hospital setting. Speaking from the San Antonio Breast Cancer Symposium (SABCS), Dr. Brown discusses cancer disparities, late-stage presentation, mistrust in the healthcare system, and the evolving landscape of breast cancer treatment. She offers a candid look at the social determinants of health shaping patient outcomes—from delayed screening and misconceptions about chemotherapy to barriers in long-term...
info_outline
Inflammation and Resistance in MDS & AML: Targeting the JAK-STAT Axis
MD Newsline
In this episode of MD Newsline, Dr. Theodoros Karantanos, Assistant Professor of Medical Oncology at the Johns Hopkins University Sidney Kimmel Cancer Center, discusses the emerging role of inflammatory signaling in high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Dr. Karantanos shares insights from his laboratory research exploring how inflammatory pathways—particularly interferon gamma and JAK-STAT signaling—contribute to treatment resistance, including resistance to venetoclax. He also highlights the impact of TP53 mutations, bone marrow microenvironment...
info_outline
Host Factors in Immunotherapy: How Sex, Aging, and Lifestyle Shape Cancer Outcomes
MD Newsline
In this episode of MD Newsline, Dr. Marco Ruella, Associate Professor of Medicine at the University of Pennsylvania and Scientific Director of the Lymphoma Program, joins us from the American Society of Hematology (ASH) meeting to discuss a paradigm-shifting topic: host factors in cancer immunotherapy. Dr. Ruella explores how biological sex, aging, chronic inflammation, obesity, exercise, and the microbiome influence responses to therapies such as checkpoint inhibitors and CAR T-cell therapy. The conversation highlights emerging data, translational research, and the growing need to...
info_outline
What’s Next for CAR-T Cells? In Vivo Design, Toxicity, and Persistence
MD Newsline
In this episode of MD Newsline, Dr. Dejah Blake, a fifth-year PhD candidate at Emory University, joins us from the American Society of Hematology (ASH) conference to discuss the rapidly evolving landscape of CAR T-cell therapy. Dejah shares insights into engineering next-generation CAR T cells, improving accessibility through in vivo manufacturing, and addressing diversity gaps in clinical research. From armored CARs to gene editing and humanized mouse models, this conversation explores how innovation and equity must move forward together in advancing cancer immunotherapy. Episode...
info_outline
The Psychology of Prevention: Behavioral Strategies for Better Health Outcomes
MD Newsline
In this episode of MD Newsline, behavioral scientist Dr. Josh Klapow, registered dietitian Kim Shapira, and health advocate Sishman Rimpson explore the powerful connection between psychology, nutrition, and long-term health outcomes. Together, they unpack how behavioral patterns, mindset, and sustainable lifestyle changes influence chronic disease prevention and patient adherence. The discussion highlights the real-world challenges patients face when attempting to modify diet, physical activity, and stress management—and how healthcare professionals can better support lasting change...
info_outline
Beyond Statins: Modern Cholesterol Care, Risk Assessment, and the Future of Lipid Therapy
MD Newsline
In this episode of MD Newsline, Dr. Amber Johnson, Assistant Professor of Medicine and General Cardiologist at the University of Chicago, provides an in-depth look at modern cholesterol management and cardiovascular risk reduction. She discusses evolving lipid guidelines, aggressive LDL-C targets, statin intolerance, and the growing role of non-statin therapies. Dr. Johnson also explores emerging research on lipoprotein(a), hypertriglyceridemia, and future directions in lipid-lowering treatment. Episode Highlights Evolving Cholesterol Management and ASCVD Risk Dr. Johnson explains how...
info_outline
Man Enough to Feel: Breaking the Stigma Around Men’s Mental Health
MD Newsline
In this episode of MD Newsline, a distinguished panel of physicians, mental health leaders, former professional athletes, and performance coaches come together for a powerful discussion on men’s mental health, vulnerability, and emotional wellbeing. The conversation explores how traditional definitions of masculinity impact mental health, performance, relationships, and help-seeking behaviors—and why redefining strength is critical for future generations. Panelists include Dr. Mike Banna, Dominique Easley, Jason Sousa, Dr. Nate Evans Jr., and Dr. Pete Thomas, each bringing unique...
info_outline
Understanding Alzheimer’s Disease: Biomarkers and Early Detection
MD Newsline
In this episode of MD Newsline, Dr. Rudolph J. Castellani, a neuropathologist and Director of the Division of Neuropathology at Northwestern University, offers a deep dive into the biology, diagnosis, and ongoing controversies surrounding Alzheimer’s disease. He explores how Alzheimer’s is defined clinically and pathologically, the evolving role of biomarkers in early detection, and why modifying biomarkers has not yet translated into meaningful clinical improvement for patients. Dr. Castellani also discusses the promise and limitations of artificial intelligence, personalized medicine,...
info_outlineIn this episode of MD Newsline, patient advocate Tameka Carter shares her personal journey living with hidradenitis suppurativa (HS), a chronic, painful inflammatory skin condition often misdiagnosed for years. Tameka discusses the early signs of HS, the emotional and physical toll of delayed diagnosis, and the importance of finding a specialist who truly listens. She offers valuable insight into treatment decision-making, lifestyle changes, and the critical role of self-advocacy in managing a lifelong condition.
Episode Highlights
Early Symptoms and Delayed Diagnosis
Tameka reflects on experiencing painful boils as early as adolescence, often dismissed as razor bumps, cysts, or irritation. Despite recurring symptoms, she did not receive an HS diagnosis until 2019—highlighting a common challenge many HS patients face.
Impact of Hormones and Life Changes
Symptoms became more frequent and severe in her early 20s, particularly after pregnancy. Over time, Tameka began noticing patterns related to her menstrual cycle, helping her better understand flare triggers.
The Emotional and Physical Burden of HS
Living with chronic pain, drainage, and scarring significantly affected Tameka’s quality of life and confidence. She shares how unmanaged HS can quietly take over daily living when symptoms become constant.
Finding the Right Specialist
Tameka emphasizes the turning point in her care after seeking a dermatologist who specializes in HS. Under the care of Dr. Onajin, she experienced a more aggressive, responsive treatment approach that prioritized real pain reduction and patient feedback.
Personalized Treatment and Pain Measurement
Rather than a one-size-fits-all approach, treatment success was measured by meaningful pain reduction percentages. This patient-centered strategy allowed Tameka and her care team to adjust therapies quickly when something wasn’t working.
Procedures, Medications, and Combination Care
Tameka discusses the role of biologics, steroid injections, surgical procedures, and scar tissue removal as part of a comprehensive treatment plan—emphasizing that improvement was gradual, not overnight.
Nutrition and Lifestyle as Key Triggers
Diet emerged as one of the most impactful factors in managing HS. Tameka shares how eliminating refined sugar, dairy, and soda helped reduce flares, improve energy levels, and support overall well-being.
Advocacy, Education, and Listening to Your Body
A strong advocate for patient education, Tameka encourages others to research their condition, speak up when treatments fail, and seek second or third opinions. She underscores that patients know their bodies best—and deserve to be heard.
Advice for Patients and Providers
Tameka offers powerful guidance for those living with HS and for healthcare providers: listen, communicate clearly, and treat patients as partners in care.
Key Takeaway
Tameka Carter’s story highlights the importance of early recognition, specialist care, and patient advocacy in managing hidradenitis suppurativa. Meaningful progress happens when patients are heard, treatments are personalized, and care teams act with urgency and compassion.